PAYS - Paysign stock falls 8% after Q4 revenue miss 2022 guidance disappoints

Paysign (NASDAQ:PAYS) stock is dropping 8.4% in after-hours trading after the provider of prepaid card programs and digital banking services issued full-year revenue guidance that trails the average analyst estimate. The company expects full-year 2022 revenue of $35.25M-$38.35M, short of the $39.6M consensus, with plasma making up ~90% of total revenue. Plasma revenue is expected to be relatively flat Y/Y as the loss of programs and settlement income in 2021 are offset with new pharma copay programs, the company said. 2022 guidance for adjusted EBITDA is $4.0M, at least double from 2021's $2.0M. Full-year gross profit margin is expected to be 50.0%-52.5%, with Q1 gross profit margin at ~60% before returning to a more normalized margin experienced in 2021. The company expects 2022 operating expenses to increase to $20.0M, up from $17.5M in 2021. Q4 GAAP EPS of $0.00 matched the consensus estimate of $0.00; compares with -$0.01 in Q3 and -$0.09

For further details see:

Paysign stock falls 8% after Q4 revenue miss, 2022 guidance disappoints